Postprandial renal haemodynamic effect of lixisenatide vs once-daily insulin-glulisine in patients with type 2 diabetes on insulin-glargine: An 8-week, randomised, open-label trial.
Lennart TonneijckMarcel H A MuskietMark M SmitsTrynke HoekstraMark H H KramerA H Jan DanserMichaela DiamantJaap A JolesDaniel H van RaaltePublished in: Diabetes, obesity & metabolism (2017)
ClinicalTrials.gov identifier NCT02276196.
Keyphrases